We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study

By MedImaging International staff writers
Posted on 23 Oct 2023
Print article
Image: New U.S. FDA-approved AI medical imaging products are expected to increase five-fold by 2035 (Photo courtesy of ACR DSI)
Image: New U.S. FDA-approved AI medical imaging products are expected to increase five-fold by 2035 (Photo courtesy of ACR DSI)

A just-released study has projected a five-fold increase in new artificial intelligence (AI) medical imaging products approved by the U.S. Food and Drug Administration (FDA) by 2035. The projection of the number of new FDA-approved products is based on the historical relationship between the number of new products and AI venture capital funding in the past.

The Harvey L. Neiman Health Policy Institute (Reston, VA, USA) and American College of Radiology Data Science Institute (Reston, VA, USA) study reveals that annual funding for AI rose from USD 2 billion in 2013 to USD 13 billion in 2022. At the current pace, it takes roughly six years from the time of funding to receiving FDA approval. The study anticipates 147 new AI products to hit the market in 2028, taking into account the USD 13 billion funding received in 2022. If the rate of funding continues to witness a similar linear trend as earlier, the study predicts that the funding will reach USD 30.8 billion in 2029, resulting in a five-fold increase in FDA-approved products by 2035.

“Given the relationship between funding and new AI products, we project there will be 350 new AI products in 2035 corresponding to the 2029 funding level given the lag between funding and approved products. This is a five-fold increase from 69 in 2022,” said Eric Christensen, PhD, Research Director at the Neiman Health Policy Institute.

“Artificial intelligence has grown rapidly and is already changing the way healthcare professionals work,” said Christopher Treml, DSI director of operations. “Based on this research, we expect that growth to continue accelerating over the next decade and change the field in new and exciting ways as AI products are developed and integrated into practice.”

Related Links:
Harvey L. Neiman HPI
ACR DSI

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
Aplio me
Ultrasound System
P20 Elite
New
Mobile Digital X-Ray System
MobileDiagnost wDR 2.1

Print article
Radcal

Channels

Radiography

view channel
Image: 3D cinematic renderings of the control and diseased heart in anatomic orientation (Photo courtesy of ESRF)

Innovative X-Ray Technique Captures Human Heart with Unprecedented Detail

Cardiovascular disease remains the leading cause of death globally. In 2019, ischemic heart disease, which weakens the heart due to reduced blood supply, accounted for approximately 8.9 million or 16%... Read more

MRI

view channel
Image: SubtleSYNTH creates synthetic STIR images with zero acquisition time that are interchangeable with conventionally acquired STIR images (Photo courtesy of Subtle Medical)

AI-Powered Synthetic Imaging Software to Further Redefine Speed and Quality of Accelerated MRI

The development of innovative solutions is not only redefining the landscape of artificial intelligence (AI)-based diagnostic imaging but also simplifying the ever-increasing complexity of workflows faced... Read more

Ultrasound

view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

General/Advanced Imaging

view channel
Image: HeartFlow Plaque Analysis leverages cutting-edge AI for assessment of plaque quantity and composition (Photo courtesy of HeartFlow, Inc.)

Next Gen Interactive Plaque Analysis Platform Assesses Patient Risk in Suspected Coronary Artery Disease

A first-of-its-kind plaque analysis tool to be fully integrated with FFRCT (when FFRCT is performed) provides impactful insights that enhance clinical decision-making and enable personalized patient treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.